EIN 20-1082179

Alzheimers Drug Discovery Foundation (ADDF)

Name: Alzheimers Drug Discovery Foundation (ADDF) financials for 2022
Creator: Cause IQ
License: https://creativecommons.org/licenses/by-nc-nd/4.0/

IRS 501(c) type

501(c)(3)

Num. employees

City

New York

State

New York

Year formed

2004

Most recent tax filings

2022-12-01

NTEE code, primary

F01: Mental Health and Crisis Intervention Alliances and Advocacy

Description

The Alzheimer's Drug Discovery Foundation's mission is to rapidly accelerate the discovery of drugs to prevent, treat and cure Alzheimer's disease.

Total revenues

$254,027,105

2022

Total expenses

$36,842,901

2022

Total assets

$340,253,841

2022

Num. employees

2022

Program areas at ADDF

The Alzheimer's Drug Discovery Foundation is dedicated to rapidly accelerating the Discovery of drugs to prevent, treat and cure Alzheimer's disease and related dementias. The addf is solely focused on funding the development of drugs for alzheimer's, employing a venture philanthropy model to support research in academia and the biotech industry.

Grants made by ADDF

Grantee	Grant description	Grant year	Amount
Scripps Research Institute	Alzheimers Research	2022-12	$3,000,000
Massachusetts General Physicians Organization	Alzheimers Research	2022-12	$963,533
University of California Santa Barbara	Alzheimers Research	2022-12	$300,000
...and 3 more grants made

Who funds Alzheimers Drug Discovery Foundation (ADDF)

Grants from foundations and other nonprofits

Grantmaker	Grantmaker tax period	Description	Amount
Fidelity Investments Charitable Gift Fund	2022-06	For Grant Recipient's Exempt Purposes	$1,127,740
Fidelity Investments Charitable Gift Fund	2022-06	For Grant Recipient's Exempt Purposes	$1,127,740
Association for Frontotemporal Degeneration (AFTD)	2023-06	Drug Discovery, Treat FTD Initiative	$700,000
...and 119 more grants received totalling $9,641,369

Personnel at ADDF

Name	Title	Compensation	Date of data
Mark Roithmayr	Chief Executive Officer	$536,310	2022-12-31
Karen Harris	Chief Financial Officer and Head of Mission Relate	$309,162	2022-12-31
Jane McIntosh	Chief External Affairs and Philanthropy Officer	$309,720	2022-12-31
Howard Fillit	Executive Director	$593,893	2023-11-15
Laura Nisenbaum	Executive Director , Drug Development	$430,343	2022-12-31
...and 10 more key personnel

Financials for ADDF

Revenues	FYE 12/2022	FYE 12/2021	% Change
Total grants, contributions, etc.	$249,842,003	$41,612,740	500.4%
Program services	$6,425,669	$9,141,360	-29.7%
Investment income and dividends	$857,675	$206,491	315.4%
Tax-exempt bond proceeds	$0	$0	-
Royalty revenue	$0	$0	-
Net rental income	$0	$0	-
Net gain from sale of non-inventory assets	$-2,911,987	$0	-999%
Net income from fundraising events	$-186,255	$2,076,513	-109%
Net income from gaming activities	$0	$0	-
Net income from sales of inventory	$0	$0	-
Miscellaneous revenues	$0	$0	-
Total revenues	$254,027,105	$53,037,104	379%

Form 990s for ADDF

Fiscal year ending	Date received by IRS	Form	PDF link
2022-12	2023-11-15	990	View PDF
2021-12	2022-11-15	990	View PDF
2020-12	2022-01-14	990	View PDF
2019-12	2021-04-05	990	View PDF
2018-12	2020-02-14	990	View PDF
...and 9 more Form 990s

Organizations like ADDF

Organization	Type	Location	Revenue
Prostate Cancer Foundation	501(c)(3)	Santa Monica, CA	$71,921,851
American Technion Society	501(c)(3)	New York, NY	$90,330,678
Orbis International	501(c)(3)	New York, NY	$138,758,305
THE Breast Cancer Research Foundation	501(c)(3)	New York, NY	$94,756,928
The Michael J. Fox Foundation for Parkinsons Research	501(c)(3)	New York, NY	$362,405,973
Lucile Packard Foundation for Children's Health	501(c)(3)	Palo Alto, CA	$230,032,578
Children's National Hospital Foundation	501(c)(3)	Washington, DC	$111,153,608
Cystic Fibrosis Foundation - Group Return for the Chapters	501(c)(3)	Bethesda, MD	$113,971,674
American Committee and the Weizmann Institute of Science	501(c)(3)	New York, NY	$154,060,000
Foundation for Innovative New Diagnostics (FIND)	501(c)(3)	Switzerland,	$144,248,069

Data update history

May 18, 2024

Received grants

Identified 4 new grant, including a grant for $44,750 from Jewish Communal Fund

February 4, 2024

Received grants

Identified 50 new grant, including a grant for $700,000 from Association for Frontotemporal Degeneration (AFTD)

January 7, 2024

Posted financials

Added Form 990 for fiscal year 2022

January 6, 2024

Updated personnel

Identified 5 new personnel

December 26, 2023

Used new vendors

Identified 3 new vendors, including , , and

Nonprofit Types

Grantmaking organizationsDisease research fundraisersMental health organizationsHeadquarter / parent organizationsCharities

Issues

HealthMental healthDiseases and disorders

Characteristics

Conducts researchFundraising eventsOperates internationallyNational levelGala fundraisersTax deductible donations

General information

Address: 57 W 57th St 904; New York, NY 10019
Metro area: New York-Newark-Jersey City, NY-NJ-PA
County: New York County, NY
Website URL: alzdiscovery.org/
Phone: (212) 901-8000
Facebook page: TheADDF
Twitter profile: @theaddf

IRS details

EIN: 20-1082179
Fiscal year end: December
Taxreturn type: Form 990
Year formed: 2004
Eligible to receive tax-deductible contributions (Pub 78): Yes

Categorization

NTEE code, primary: F01: Mental Health and Crisis Intervention Alliances and Advocacy
NAICS code, primary: 813212: Health and Disease Research Fundraising Organizations
Parent/child status: Central organization

Blog articles

Free account sign-up

Want updates when ADDF has new information, or want to find more organizations like Alzheimers Drug Discovery Foundation (ADDF)?

Create free Cause IQ account

Alzheimers Drug Discovery Foundation (ADDF)

Program areas at ADDF

Grants made by ADDF

Who funds Alzheimers Drug Discovery Foundation (ADDF)

Personnel at ADDF

Financials for ADDF

Form 990s for ADDF

Organizations like ADDF

Nonprofits

Product

Customers

About